[{"address1": "4640 Admiralty Way", "address2": "Suite 500", "city": "Marina del Rey", "state": "CA", "zip": "90292", "country": "United States", "phone": "310 496 5744", "fax": "310 943 1457", "website": "https://viadermalicensing.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as D\u00e9cor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Qing Hua Lin", "age": 41, "title": "Chief Financial Officer and Director", "yearBorn": 1981, "fiscalYear": 2011, "totalPay": 4455, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Baotang  Zhao", "age": 44, "title": "Chief Sales Officer", "yearBorn": 1978, "fiscalYear": 2011, "totalPay": 28766, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Zhang  Xie", "age": 43, "title": "Corporate Secretary and Director", "yearBorn": 1979, "fiscalYear": 2011, "totalPay": 9178, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher A Otiko", "title": "Founder, Chief Executive Officer and President", "fiscalYear": 2011, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew  Berman M.D., MPH", "title": "Medical Director and Member of Advisory Board", "fiscalYear": 2011, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1325289600, "maxAge": 86400, "priceHint": 4, "previousClose": 0.010505, "open": 0.0087, "dayLow": 0.0087, "dayHigh": 0.01145, "regularMarketPreviousClose": 0.010505, "regularMarketOpen": 0.0087, "regularMarketDayLow": 0.0087, "regularMarketDayHigh": 0.01145, "payoutRatio": 0.0, "beta": -0.143, "trailingPE": 0.03578125, "volume": 455239, "regularMarketVolume": 455239, "averageVolume": 1228627, "averageVolume10days": 986240, "averageDailyVolume10Day": 986240, "marketCap": 83766, "fiftyTwoWeekLow": 0.004, "fiftyTwoWeekHigh": 0.03, "priceToSalesTrailing12Months": 1.8743371, "fiftyDayAverage": 0.01126, "twoHundredDayAverage": 0.012635, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 5789718, "profitMargins": 0.0, "sharesOutstanding": 137322, "impliedSharesOutstanding": 6866070, "bookValue": -0.002, "lastFiscalYearEnd": 1514678400, "nextFiscalYearEnd": 1546214400, "mostRecentQuarter": 1514678400, "netIncomeToCommon": -1518384, "trailingEps": 0.32, "enterpriseToRevenue": 129.55, "enterpriseToEbitda": -9.773, "52WeekChange": 0.8333334, "SandP52WeekChange": 0.24536526, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "VDRM", "underlyingSymbol": "VDRM", "shortName": "VIADERMA INC", "longName": "ViaDerma, Inc.", "firstTradeDateEpochUtc": 1414762200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "133ca6cf-b008-3b19-933a-6128d892b6ee", "messageBoardId": "finmb_61468192", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.01145, "recommendationKey": "none", "totalCash": 13082, "totalCashPerShare": 0.0, "ebitda": -592435, "totalDebt": 423663, "quickRatio": 0.271, "currentRatio": 0.286, "totalRevenue": 44691, "revenuePerShare": 0.0, "returnOnAssets": -0.91229, "grossProfits": 37629, "freeCashflow": 688402, "operatingCashflow": -167361, "revenueGrowth": -0.578, "grossMargins": 0.84198, "ebitdaMargins": 0.0, "operatingMargins": -5.85499, "financialCurrency": "USD", "trailingPegRatio": null}]